Induced pluripotent stem cell technology: a decade of progress.

Shi, Yanhong, Inoue, Haruhisa, Wu, Joseph C., Yamanaka, Shinya·2017·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2016.245

Cites (224)

Items 201–224 of 224

  1. Discovery of Inhibitors of Microglial Neurotoxicity Acting Through Multiple Mechanisms Using a Stem-Cell-Based Phenotypic Assay
    Susanne Höing, York Rudhard, Peter Reinhardt, Michael Glatza, Martin Stehling, Guangming Wu, Christiane Peiker, Alexander Böcker, Juan A. Parga, Eva Christine Bunk et al. · 2012 · Cell stem cell
  2. Expanding the boundaries of embryonic stem cells.
    Uri Ben-David, O. Kopper, N. Benvenisty · 2012 · Cell Stem Cell
  3. Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes
    Erpo Tian, Guoqiang Sun, Guihua Sun, Jianfei Chao, Peng Ye, Charles Warden, Arthur D. Riggs, Yanhong Shi · 2016 · Cell Reports
  4. Do Human Leukocyte Antigen-Typed Cellular Therapeutics Based on Induced Pluripotent Stem Cells Make Commercial Sense?
    Christopher A. Bravery · 2014 · Stem Cells and Development
  5. APP Processing in Human Pluripotent Stem Cell-Derived Neurons Is Resistant to NSAID-Based γ-Secretase Modulation
    Jérôme Mertens, Kathrin Stüber, Patrick Wunderlich, Julia Ladewig, Jaideep Kesavan, Rik R. Vandenberghe, Mathieu Vandenbulcke, Philip Van Damme, Jochen Walter, Oliver Brüstle et al. · 2013 · Stem Cell Reports
  6. Noninvasive De novo Imaging of Human Embryonic Stem Cell–Derived Teratoma Formation
    Feng Cao, Zibo Li, Andrew Stephen Lee, Zhaofei Liu, Kai Chen, Hui Wang, Weibo Cai, Xiaoyuan Shawn Chen, Joseph C. Wu · 2009 · Cancer Research
  7. Strategy for the creation of clinical grade hESC line banks that HLA‐match a target population
    Laureen Jacquet, Emma Stephenson, Robert Collins, Heema Patel, Jane Trussler, Roaa Al‐bedaery, Pamela Renwick, Caroline Mackie Ogilvie, Robert Vaughan, Duško Ilić · 2012 · EMBO Molecular Medicine
  8. Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells
    Meng Li, Huashan Zhao, Gene E. Ananiev, Michael Tuttle Musser, Kathryn H. Ness, Dianne L. Maglaque, Krishanu Saha, Anita Bhattacharyya, Xinyu Zhao · 2016 · Stem Cells
  9. Stem-cell discovery platforms yield first clinical candidates
    Asher Mullard · 2015 · Nature Reviews Drug Discovery
  10. Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction
    Chao Li, Lei Ding, Chiao‐Wang Sun, Li-Chen Wu, Dewang Zhou, Kevin M. Pawlik, Alireza Khodadadi‐Jamayran, Erik R. Westin, Frederick D. Goldman, Tim M. Townes · 2016 · Scientific Reports
  11. Identification of rare variants in Alzheimer’s disease
    Jenny Lord, Alexander J. Lu, Carlos Cruchaga · 2014 · Frontiers in Genetics
  12. In vitro organogenesis from pluripotent stem cells
    Yan Li, Chunhui Xu, Teng Ma · 2014 · Organogenesis
  13. Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas
    Johannes Riegler, Antje Ebert, Xulei Qin, Qi Shen, Mouer Wang, Mohamed Ameen, Kazuki Kodo, Sang‐Ging Ong, Won Hee Lee, Grace Lee et al. · 2016 · Stem Cell Reports
  14. Does Retroviral Insertional Mutagenesis Play a Role in the Generation of Induced Pluripotent Stem Cells?
    Robert G. Hawley · 2008 · Molecular Therapy
  15. Reprogramming cell fates: insights from combinatorial approaches
    Carlos‐Filipe Pereira, Ihor R. Lemischka, Kateri Ann Moore · 2012 · Annals of the New York Academy of Sciences
  16. Transdifferentiation via transcription factors or microRNAs: Current status and perspective
    Huan Wang, Xiao Li, Shutao Gao, Xuying Sun, Huang Fang · 2015 · Differentiation
  17. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
    Samantha Seah, Chadi A. El Farran, Tushar Warrier, Jian Xu, Yuin‐Han Loh · 2015 · International Journal of Molecular Sciences
  18. iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System
    Andrés J. Orqueda, Carla Alejandra Giménez, Federico Pereyra-Bonnet · 2016 · Stem Cells International
  19. Genome editing in pluripotent stem cells: research and therapeutic applications
    Michela Deleidi, Cong Yu · 2016 · Biochemical and Biophysical Research Communications
  20. Current Public Support for Human-Animal Chimera Research in Japan Is Limited, Despite High Levels of Scientific Approval
    Yusuke Inoue, Ryuma Shineha, Yoshimi Yashiro · 2016 · Cell stem cell
  21. Neural progenitor cells from human induced pluripotent stem cells generated less autogenous immune response
    Ke Huang, Pengfei Liu, Xiang Li, Shubin Chen, LiHui Wang, Li Qin, Zhenghui Su, Wenhao Huang, Juli Liu, Bei Jia et al. · 2014 · Science China Life Sciences
  22. In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination
    Michelle J. Smith, Beau R. Webber, Mahmood Mohtashami, Heather Emily Stefanski, Juan Carlos Zúñiga‐Pflücker, Bruce R. Blazar · 2015 · Stem Cells
  23. Induced pluripotent stem cell-derived myeloid phagocytes: disease modeling and therapeutic applications
    Helen S. Goodridge · 2014 · Drug Discovery Today
  24. 10 Questions: Clinical Outlook for iPSCs
    Cell Stem Cell Editorial Team∗ · 2016 · Cell stem cell